Observational studyBMC medicine2025
Long-term psychological effects of COVID-19-related quarantine: an observational study of three cohorts in Norway and Iceland.
Observational study in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundLongitudinal assessments of psychological effects related to length and recency of quarantine experience in general populations are of importance. We aim to investigate if recency and duration of quarantine exposures during the COVID-19 pandemic were associated with mental health, across subgroups.
methodsWe included three prospective cohorts from Iceland and Norway with data on quarantine and symptoms of depression and anxiety from March 2020 to March 2022. We calculated prevalence ratios (PR) of probable depression and anxiety in relation to quarantine exposure, and performed longitudinal analyses in a subpopulation with repeated assessments to test the potential change in mental health burden due to quarantine over time while controlling for current quarantine status and other covariates.
resultsIn total, 105,344 and 94,435 individuals were included in the analysis of probable depression and anxiety, respectively, with 18.2% and 40.0% reporting quarantine exposure before the most recent assessment of corresponding mental health symptoms. Overall, quarantine exposure was associated with probable depression (PR 1.19 [95% CI: 0.99-1.42]) and anxiety (PR 1.21 [1.08-1.36]). Compared to individuals without quarantine, being exposed to quarantine for 0-2, 2-4, or > 4 weeks was associated with incrementally higher prevalence of probable depression (PR 1.15 [0.93-1.43]; 1.34 [1.06-1.68]; 1.72 [1.35-2.18], respectively) and probable anxiety (PR 1.12 [1.01-1.23]; 1.28 [1.14-1.45]; 1.76 [1.56-1.98]) in a step-wise manner; those who were quarantined within the last 2 weeks, last 2-4 weeks, or earlier showed a higher prevalence of probable depression in a dose-response manner (PR 1.62 [1.32-1.99], 1.32 [1.07-1.63], and 1.23 [1.06-1.43], respectively). The prevalence of probable anxiety did not appear to differ by the recency of quarantine. The longitudinal analyses (mean follow-up: 20.5 months) confirmed significantly higher prevalence of probable depression but only among those who were quarantined for > 4 weeks (PR 1.61 [1.30-2.00]), and of probable anxiety among those quarantined 2-4 weeks (PR 1.29 [1.14-1.45]) and > 4 weeks (PR 1.56 [1.34-1.82]).
conclusionsThis study underscores the importance of monitoring mental well-being of populations recently quarantined, particularly those quarantined for prolonged periods. Greater emphasis should be placed on the detrimental psychological effects in the risk-cost-benefit analysis of quarantine as a mitigation strategy in future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.